Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Attenuat CLA
- Development stage
- Unknown
- Lead developer
- Laboratorios Lafedar
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Attenuat CLA is a nutraceutical product developed and marketed by Laboratorios Lafedar, an Argentine pharmaceutical company. The active ingredient is conjugated linoleic acid (CLA), a naturally occurring fatty acid provided in 1000 mg capsules. It is marketed as a dietary supplement with weight loss (adelgazante) and energizing (energizante) properties. CLA is believed to influence body composition by modulating lipid metabolism, specifically by inhibiting fat storage in adipose tissue and promoting fatty acid oxidation in muscle. In the Argentine market, Attenuat CLA is classified and approved as a nutraceutical/dietary supplement rather than a prescription pharmaceutical medication.
- Brand names
- Attenuat CLA
- Other names
- Ácido Linoleíco ConjugadoConjugated Linoleic Acid
02
Targets
LPL (Lipoprotein lipase)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on Attenuat CLA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Attenuat CLA.